BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30282375)

  • 1. Home-Based Monitoring of Pulmonary Function in Patients with Duchenne Muscular Dystroph.
    Buyse GM; Rummey C; Meier T; Leinonen M; Voit T; McDonald CM; Mayer OH
    J Neuromuscul Dis; 2018; 5(4):419-430. PubMed ID: 30282375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial.
    Buyse GM; Voit T; Schara U; Straathof CSM; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; McDonald CM; Rummey C; Meier T;
    Lancet; 2015 May; 385(9979):1748-1757. PubMed ID: 25907158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy.
    Buyse GM; Goemans N; van den Hauwe M; Meier T
    Pediatr Pulmonol; 2013 Sep; 48(9):912-20. PubMed ID: 23129412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy.
    Meier T; Rummey C; Leinonen M; Spagnolo P; Mayer OH; Buyse GM;
    Neuromuscul Disord; 2017 Apr; 27(4):307-314. PubMed ID: 28189481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy.
    Buyse GM; Voit T; Schara U; Straathof CS; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; Rummey C; Leinonen M; Mayer OH; Spagnolo P; Meier T; McDonald CM;
    Pediatr Pulmonol; 2017 Apr; 52(4):508-515. PubMed ID: 27571420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy.
    Mayer OH; Leinonen M; Rummey C; Meier T; Buyse GM;
    J Neuromuscul Dis; 2017; 4(3):189-198. PubMed ID: 28869486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy.
    McDonald CM; Meier T; Voit T; Schara U; Straathof CS; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; Rummey C; Leinonen M; Spagnolo P; Buyse GM;
    Neuromuscul Disord; 2016 Aug; 26(8):473-80. PubMed ID: 27238057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy.
    Servais L; Straathof CSM; Schara U; Klein A; Leinonen M; Hasham S; Meier T; De Waele L; Gordish-Dressman H; McDonald CM; Mayer OH; Voit T; Mercuri E; Buyse GM;
    Neuromuscul Disord; 2020 Jan; 30(1):5-16. PubMed ID: 31813614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial.
    Buyse GM; Goemans N; van den Hauwe M; Thijs D; de Groot IJ; Schara U; Ceulemans B; Meier T; Mertens L
    Neuromuscul Disord; 2011 Jun; 21(6):396-405. PubMed ID: 21435876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pulmonary function in Duchenne Muscular Dystrophy.
    Mayer OH; Finkel RS; Rummey C; Benton MJ; Glanzman AM; Flickinger J; Lindström BM; Meier T
    Pediatr Pulmonol; 2015 May; 50(5):487-94. PubMed ID: 25755201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is It Possible to Have Home E-Monitoring of Pulmonary Function in Our Patients with Duchenne Muscular Dystrophy in the COVID-19 Pandemic?-A One Center Pilot Study.
    Wasilewska E; Sobierajska-Rek A; Małgorzewicz S; Soliński M; Szalewska D; Jassem E
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of Telemonitoring of Pulmonary Function-3-Month Follow-Up of Home Electronic Spirometry in Patients with Duchenne Muscular Dystrophy.
    Wasilewska E; Sobierajska-Rek A; Małgorzewicz S; Soliński M; Jassem E
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids.
    McDonald CM; Gordish-Dressman H; Henricson EK; Duong T; Joyce NC; Jhawar S; Leinonen M; Hsu F; Connolly AM; Cnaan A; Abresch RT;
    Neuromuscul Disord; 2018 Nov; 28(11):897-909. PubMed ID: 30336970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy.
    McKim DA; Katz SL; Barrowman N; Ni A; LeBlanc C
    Arch Phys Med Rehabil; 2012 Jul; 93(7):1117-22. PubMed ID: 22421625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
    Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
    Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of body habitus and respiratory function in Duchenne muscular dystrophy.
    Chew K; Carey K; Ho G; Mallitt KA; Widger J; Farrar M
    Respir Med; 2016 Oct; 119():35-40. PubMed ID: 27692145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.
    Andrews JG; Soim A; Pandya S; Westfield CP; Ciafaloni E; Fox DJ; Birnkrant DJ; Cunniff CM; Sheehan DW;
    Respir Care; 2016 Oct; 61(10):1349-59. PubMed ID: 27507176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in Lung Volume With Duchenne Muscular Dystrophy Is Associated With Ventilation Inhomogeneity.
    Stehling F; Dohna-Schwake C; Mellies U; Große-Onnebrink J
    Respir Care; 2015 Sep; 60(9):1257-63. PubMed ID: 25944942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
    Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
    Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy.
    Sawnani H; Horn PS; Wong B; Darmahkasih A; Rybalsky I; Shellenbarger KC; Tian C; Rutter MM; Simakajornboon N; Amin R; Gurbani N; Pascoe J; Burrows C; Khirani S; Amaddeo A; Fauroux B
    J Pediatr; 2019 Jul; 210():194-200.e2. PubMed ID: 30955791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.